A trio of major studies found that finerenone may protect the kidneys and heart in far more people than previously thought. The drug significantly slowed kidney disease progression and reduced the risks of kidney failure, heart failure, cardiovascular death, and overall mortality. Researchers saw be nefits not only in patients with diabetes but also in those with non-diabetic kidney disease, a group with limited treatment options. ...read more read less